During the last session, BriaCell Therapeutics Corp (NASDAQ:BCTX)’s traded shares were 19.8 million, with the beta value of the company hitting 1.37. At the end
In today’s recent session, 17.9 million shares of the BriaCell Therapeutics Corp (NASDAQ:BCTX) have been traded, and its beta is 1.37. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
